Expression of CD21 is developmentally regulated during thymic maturation of human T lymphocytes

International Immunology

Volumn 11, Issue 11, 1999, Pages 1841-1849

  Fischer, Elizabeth M ^a   Mouhoub, Amal ^a   Maillet, Françoise ^a   Frémeaux Bacchi, Véronique ^a   Krief, Corinne ^a   Gould, Hannah ^a,b   Berrih Aknin, Sonia ^a,c   Kazatchkine, Michel D ^a  

^a HÔPITAL BROUSSAIS   (France)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

Author keywords

CD23; Epstein Barr virus; Maturation; Thymocytes

Indexed keywords

CD1 ANTIGEN; CD23 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; BLOOD; CELL MATURATION; CHILD; DOWN REGULATION; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PHENOTYPE; PRIORITY JOURNAL; STAINING; T LYMPHOCYTE; THYMOCYTE; THYMUS;

CELL DIFFERENTIATION; CELLS, CULTURED; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HERPESVIRUS 4, HUMAN; HUMANS; INFANT; INFANT, NEWBORN; LYMPHOCYTE ACTIVATION; PRECIPITIN TESTS; RECEPTORS, COMPLEMENT 3D; RECEPTORS, IGE; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0032717302     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/11.11.1841     Document Type: Article

References (43)

1. Weis, J. J., Tedder, T. F. and Fearon, D. T. 1984. Identification of a 145 000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes. Proc. Natl Acad. Sci. USA 81:881.
2. Aubry, J., Pochon, S., Graber, P., Jansen, K. and Bonnefoy, J. 1992. CD21 is a ligand for CD23 and regulates IgE production. Nature 358:505.
3. Fingeroth, J. D., Weis, J. J., Tedder, T. F., Strominger, J. L., Biro, P. A. and Fearon, D. T. 1984. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc. Natl Acad. Sci. USA 81:4510.
4. Ahearn, J. M. and Fearon, D. T. 1989. Structure and function of the complement receptors CR1 (CD35) and CR2 (CD21). Adv. Immunol. 46:183.
5. Matsumoto, A. K., Kopicky-Burd, J., Carter, R. H., Tuveson, D. A., Tedder, T. F. and Fearon, D. T. 1991. Intersection of the complement and immune system: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19. J. Exp. Med. 173:55.
6. Bradbury, L. E., Kansas, G. S., Levy, S., Evans, R. L. and Tedder, T. F. 1992. The CD19/CD21 signal transducting complex of human B lymphocytes includes the target of anti-proliferative antibody and leu-13 molecules. J. Immunol. 149:2841.
7. Bohnsack, J. F. and Cooper, N. R. 1988. CR2 ligands modulate human B cell activation. J. Immunol. 141:2569.
8. Carter, R. H., Spycher, M. O., Ng, Y. C., Hoffman, R. and Fearon, D. T. 1988. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J. Immunol. 141:457.
9. Bonnefoy, J. Y., Henchoz, S., Hardie, D., Holder, M. J. and Gordon, J. 1993. A subset of anti-CD21 antibodies promote the rescue of germinal center B cells from apoptosis. Eur. J. Immunol. 23:969.
10. Nemerow, G. R. and Cooper, N. R. 1984. Early events in the infection of human B lymphocytes by Epstein-Barr virus: the internalization process. Virology 132:186.
11. Tanner, J., Weis, J., Fearon, D., Whang, Y. and Kieff, E. 1987. Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping and endocytosis. Cell 50:203.
12. Miller, G. 1990. Epstein-Barr virus, biology, pathogenesis and medical aspects. In Fields, B. N. B., and Knipe, D. M., eds, Epstein-Barr Virus, Biology, Pathogenesis and Medical Aspects, p. 1921. Raven Press, New York.
13. Fox, R. I., Luppi, M., Pisa, P. and Kang, H. I. 1992. Potential role of Epstein-Barr virus in Sjögren's syndrome and rheumatoid arthritis. J. Rheumatol. 32:18.
14. Tsoukas, C. D. and Lambris, J. D. 1988. Expression of CR2/ EBV receptor on human thymocytes detected by monoclonal antibodies. Eur. J. Immunol. 18:1299.
15. Reynes, M., Aubert, J. P., Cohen, J. H. M., Audouin, J., Tricottet, V., Diebold, J. and Kazatchkine, M. D. 1985. Human follicular dendritic cells express CR1, CR2 and CR3 complement receptor antigens. J. Immunol. 135:2687.
16. Fischer, E., Delibrias, C. and Kazatchkine, M. D. 1991. Expression of CR2 (the C3dg/EBV receptor CD21) on normal human peripheral blood human T lymphocytes. J. Immunol. 146:865.
17. Gasque, P., Chan, P., Mauger, C., Schouft, M. T., Dierich, M. P., Morgan, B. P. and Fontaine, M. 1996. Expression of complement receptor 2 (CR2, CD21), the receptor for Epstein-Barr virus and complement C3d, on human brain cells. J. Immunol. 156:2247.
18. Sixbey, J. W., Davis, D. S., Young, L. S., Hutt-Fletcher, L., Tedder, T. F. and Rickinson, A. B. 1987. Human epithelial expression of an Epstein-Barr virus receptor. J. Gen. Virol. 68:805.
19. Delibrias, C., Fischer, E., Bismuth, G. and Kazatchkine, M. D. 1992. Expression, molecular association, and functions of C3 receptors CR1 (CD35) and CR2 (CD21) on the human T cell line HPB-ALL. J. Immunol. 149:768.
20. Delibrias, C. C., Mouhoub, A., Kazatchkine, M. D. and Fischer, E. 1994. CR1 (CD35) and CR2 (CD21) complement C3 receptors are expressed on normal human thymocytes and mediate infection of thymocytes with opsonized human immunodeficiency virus. Eur. J. Immunol. 24:2784.
21. Cook, J., Fischer, E., Boucheix, C., Mirsrahi, M., Jouvin, M. H., Weiss, L., Jack, R. and Kazatchkine, M. D. 1985. Mouse monoclonal antibodies to the human C3b receptor. Mol. Immunol. 22:531.
22. Thornton, B., Vetvicka, V. and Ross, G. 1994. Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. J. Immunol. 152:1727.
23. Reljic, R., Cosentino, G. and Goulds, H. 1997. Function of CD23 in the response of human B cells to antigen. Eur. J. Immunol. 27:572.
24. Spits, H. 1994. Early stages in human and mouse T-cell development. Curr. Opin. Immunol. 6:212.
25. Mossalayi, M., Lecron, J., Dalloul, A., Sarfati, M., Bertho, J., Hofstetter, H., Delespesse, G. and Debré, P. 1990. Soluble CD23 (FcεRII) and interleukin 1 synergistically induce early human thymocyte maturation. J. Exp. Med. 171:959.
26. Wells, A., Steen, H. B., Godal, T. and Klein, G. 1981. Epstein-Barr virus receptor expression is correlated to cell cycle phase. J. Receptor Res. 2:285.
27. Schmitt, C., Ktorza, S., Sarun, S., Blanc, C., Jong, R. D. and Debré, P. 1994. CD34-expressing human thymocyte precursors proliferate in response to interleukin-7 but have lost myeloid differentiation potential. Blood. 82:3675.
28. Tedder, T. F., Clement, L. T. and Cooper, M. D. 1984. Expression of C3d receptors during human B cell differenciation: immunofluorescence analysis with HB5 monoclonal antibodies. J. Immunol. 146:865.
29. Rayhel, E. J., Dehoff, M. H. and Holers, V. M. 1991. Characterization of the human complement receptor 2 (CR2/ CD21) promoter reveals sequences shared with regulatory regions of other developmentally restricted B cell proteins. J. Immunol. 146:2021.
30. Makar, W., Pham, C. T. N., Dehoff, M. H., O'Connor, S. M., Jacobi, S. M. and Holers, V. M. 1998. An intronic silencer regulates B lymphocyte cell-and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene. J. Immunol. 160:1268.
31. Siu, G., Wurster, A. L., Duncan, D. D., Soliman, T. M. and Hedrick, S. M. 1994. A transcriptional silencer controls the developmental expression of the CD4 gene. EMBO J. 13:3570.
32. Anderson, G., Moore, N. C., Owen, J. J. T. and Jenkinson, E. J. 1996. Cellular interactions in thymocyte development. Annu. Rev. Immunol. 14:73.
33. Kaufman-Paterson, R. L., Kelleher, C. A., Streib, J. E., Amankonah, T. D., Wu Xu, J., Jones, J. F. and Gelfand, E. W. 1995. Activation of human thymocytes after infection by EBV. J Immunol. 154:1440.
34. Prodinger, W. M., Larcher, C., Schwendinger, M. and Dierich, M. P. 1996. Ligation of the functional domain of complement receptor type 2 (CR2, CD21) is relevant for complex formation in T cell lines. J. Immunol. 156:2580.
35. Ritter, M. A. and Boyd, R. L. 1993. Development in the thymus: it takes two for a tango. Immunol. Today 14:462.
36. Dalloul, A. H., Fourcade, C., Debré, P. and Mossalayi, M. D. 1991. Thymic epithelial cell-derived supernatants sustain the maturation of human prothymocytes: involvement of interleukin 1 and CD23. Eur. J. Immunol. 21:2633.
37. Todd, S. C. and Tsoukas, C. D. 1996. EBV induces proliferation of immature human thymocytes in an IL-2-mediated response. J. Immunol. 156:4217.
38. Watry, D., Hedrick, J. A., Siervo, S., Rhodes, G., Lamberti, J. J., Lambris, J. D. and Tsoukas, C. D. 1991. Infection of human thymocytes by Epstein-Barr virus. J. Exp. Med. 173:971.
39. Kaufman-Paterson, R. L., Kelleher, C. A., Amankonah, T. D., Streib, J. E., Wu Xu, J., Jones, J. F. and Gelfand, E. W. 1995. Model of Epstein-Barr virus infection of human thymocytes: expression of viral genome and impact on cellular receptor expression in the T-lymphoblastic cell line, HPB-ALL. Blood 85:456.
40. Kelleher, C. A., Kaufman-Paterson, R. L., Dreyfus, D. H., Streib, J. E., Wu Xu, J., Takase, K., Jones, J. F. and Gelfand, E. W. 1995. Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: simultaneous early expression of BZLF-1 and its repressor RAZ. Virology 208:685.
41. Gutsch, D. E., Holley-Guthrie, E. A., Zhang, Q., Stein, B., Blanar, M. A., Baldwin, A. S. and Kenney, S. C. 1994. The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kB. Mol. Cell. Biol. 14:1939.
42. Farrell, P. J., Rowe, D. T., Rooney, C. M. and Kouzarides, T. 1989. Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos. EMBO J. 8:127.
43. Dreyfus, D. H., Kelleher, C. A., Jones, J. and Gelfand, E.W., 1996. Epstein-Barr virus infection of T cells: implications for altered T-lymphocyte activation, repertoire development and autoimmunity. Immunol. Rev. 152:89.